Exploiting synthetic lethality to target BRCA1/2-deficient tumors: where we stand
Crossref DOI link: https://doi.org/10.1038/s41388-021-01744-2
Published Online: 2021-03-14
Published Print: 2021-04-29
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Patel, Parasvi S.
Algouneh, Arash
Hakem, Razq http://orcid.org/0000-0001-5948-7931
Text and Data Mining valid from 2021-03-14
Version of Record valid from 2021-03-14
Article History
Received: 3 December 2020
Revised: 21 February 2021
Accepted: 26 February 2021
First Online: 14 March 2021
Compliance with ethical standards
:
: The authors declare no competing interests.